| 2025 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 118,4 M € | -48.2% | 228,6 M € | +17.3% | 194,9 M € | +7.4% | 181,5 M € | +53.5% | 118,2 M € | -23.8% | 155,2 M € | +40.5% | 110,5 M € | +13.2% | 97,6 M € | -5.5% | 103,2 M € | +22.2% | 84,5 M € | +9.0% | 77,5 M € | -1.5% | 78,7 M € | +6.7% | 73,7 M € | +15.3% | 63,9 M € | |
| EBITDA | 13,7 M € | -61.4% | 35,4 M € | +14.6% | 30,9 M € | -40.0% | 51,5 M € | +42.1% | 36,2 M € | +17.3% | 30,9 M € | +42.8% | 21,6 M € | +6.2% | 20,4 M € | +5.9% | 19,2 M € | +19.7% | 16,1 M € | +15.7% | 13,9 M € | +1.6% | 13,7 M € | +24.6% | 11,0 M € | +45.3% | 7,6 M € | |
| Operating profit | 9,1 M € | -72.6% | 33,1 M € | +19.1% | 27,8 M € | -44.4% | 49,9 M € | +53.4% | 32,6 M € | +19.4% | 27,3 M € | +43.5% | 19,0 M € | -4.6% | 19,9 M € | +6.1% | 18,8 M € | +29.8% | 14,5 M € | +18.8% | 12,2 M € | +7.3% | 11,4 M € | +26.3% | 9,0 M € | +150.1% | 3,6 M € | |
| Profit/loss | 8,1 M € | -68.2% | 25,6 M € | +23.1% | 20,8 M € | -44.9% | 37,7 M € | +63.7% | 23,0 M € | +18.9% | 19,3 M € | +41.7% | 13,7 M € | +8.6% | 12,6 M € | +1.1% | 12,4 M € | +43.0% | 8,7 M € | +30.6% | 6,7 M € | -14.8% | 7,8 M € | +46.7% | 5,3 M € | +147.4% | 2,2 M € | |
| Equity | 158,3 M € | +13.5% | 139,4 M € | +22.4% | 113,9 M € | +22.3% | 93,1 M € | +27.4% | 73,1 M € | +45.9% | 50,1 M € | +43.4% | 34,9 M € | +46.9% | 23,8 M € | +0.3% | 23,7 M € | +65.7% | 14,3 M € | +6.7% | 13,4 M € | -2.5% | 13,8 M € | +29.2% | 10,6 M € | +72.9% | 6,2 M € | |
| Total assets | 193,1 M € | -3.1% | 199,3 M € | +1.1% | 197,0 M € | +15.5% | 170,6 M € | +7.0% | 159,5 M € | +27.8% | 124,8 M € | +55.0% | 80,5 M € | +52.0% | 53,0 M € | -16.7% | 63,6 M € | +36.9% | 46,4 M € | -15.2% | 54,7 M € | -1.0% | 55,2 M € | -0.5% | 55,5 M € | +17.9% | 47,1 M € | |
| Cash | 457,1 k € | +7.5% | 425,4 k € | +99.3% | 213,4 k € | -55.3% | 477,3 k € | -93.3% | 7,1 M € | +9.7% | 6,5 M € | -62.3% | 17,1 M € | +141.8% | 7,1 M € | -55.0% | 15,8 M € | +23.4% | 12,8 M € | -18.1% | 15,6 M € | +64.1% | 9,5 M € | +893.0% | 956,7 k € | -53.5% | 2,1 M € | |
| Debts | 34,8 M € | -41.8% | 59,8 M € | -28.0% | 83,1 M € | +7.4% | 77,4 M € | -9.9% | 85,9 M € | +16.2% | 73,9 M € | +73.6% | 42,6 M € | +90.3% | 22,4 M € | -28.2% | 31,2 M € | +38.5% | 22,5 M € | -25.6% | 30,2 M € | -8.2% | 32,9 M € | -10.2% | 36,6 M € | +0.6% | 36,4 M € | |
| Staff | 38,2 | 39,5 | 38,9 | 38,3 | 38,6 | 34,1 | 34,1 | 34,5 | 34,6 | 26,4 | 24,2 | 23,2 | 21,9 | 21 | ||||||||||||||
Private limited company · Seraing · incorporated on 23/11/2005 · 38,2 ETP
Private limited company profitable and well capitalised. Cash position rising (+7.5%).
Solid counterparty for a standard engagement.
ARYSTA LIFESCIENCE BENELUX is a Private limited company incorporated in 2005. Its main activity is: Manufacture of pesticides and other agrochemical products. Its registered office is in Seraing. It employs on average 38,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette